Literature DB >> 8274481

Cytokines decrease apolipoprotein accumulation in medium from Hep G2 cells.

W H Ettinger1, V K Varma, M Sorci-Thomas, J S Parks, R C Sigmon, T K Smith, R B Verdery.   

Abstract

Cytokines, important biochemical mediators of inflammation, cause a rapid fall in the plasma concentration of cholesterol in vivo. One mechanism by which cytokines may cause acquired hypocholesterolemia is by decreasing the hepatic synthesis and secretion of apolipoproteins. To test this hypothesis, we incubated Hep G2 cells with human recombinant tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6. Each of the cytokines resulted in a dose-related reduction in the concentrations of apolipoprotein (apo) A-I, apoB, and lecithin:cholesterol acyltransferase (LCAT) activity in the medium after 24 hours of incubation. The effect of cytokines on apolipoprotein accumulation was not affected by preincubation of Hep G2 cells with fatty acids. Cytokines decreased the concentration of cellular apoA-I mRNA in a dose-related fashion but did not affect cellular concentrations of apoB mRNA. The concentrations of triglyceride and cholesterol were also reduced in the medium of cells incubated with cytokines. Total cell sterol synthesis rates were calculated by [14C]acetate incorporation. Cells incubated with interleukin-6 had a 31% increase in sterol synthesis rate but a 41% decrease in sterol secretion. These data suggest that these cytokines can decrease the hepatic synthesis and/or secretion of apolipoproteins and that this may explain, in part, the acquired hypocholesterolemia seen during acute and chronic inflammation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8274481     DOI: 10.1161/01.atv.14.1.8

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  32 in total

1.  Adrenal-exhaustion syndrome in patients with liver disease.

Authors:  Paul E Marik
Journal:  Intensive Care Med       Date:  2006-01-24       Impact factor: 17.440

Review 2.  Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm.

Authors:  Jamie Robertson; Mike J Peters; Iain B McInnes; Naveed Sattar
Journal:  Nat Rev Rheumatol       Date:  2013-06-18       Impact factor: 20.543

Review 3.  Therapeutic interventions to enhance apolipoprotein A-I-mediated cardioprotection.

Authors:  Michael J Haas; Arshag D Mooradian
Journal:  Drugs       Date:  2010-05-07       Impact factor: 9.546

4.  Apolipoprotein A-I mimetic peptide treatment inhibits inflammatory responses and improves survival in septic rats.

Authors:  Zhenghao Zhang; Geeta Datta; Yun Zhang; Andrew P Miller; Paulina Mochon; Yiu-Fai Chen; John Chatham; G M Anantharamaiah; C Roger White
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-06-26       Impact factor: 4.733

Review 5.  Emerging hepatic syndromes: pathophysiology, diagnosis and treatment.

Authors:  Gaetano Bertino; Graziella Privitera; Francesco Purrello; Shirin Demma; Emanuele Crisafulli; Luisa Spadaro; Nikolaos Koukias; Emmanuel A Tsochatzis
Journal:  Intern Emerg Med       Date:  2016-06-07       Impact factor: 3.397

6.  Impaired absorption of cholesterol and bile acids in patients with an ileoanal anastomosis.

Authors:  K Hakala; M Vuoristo; P Luukkonen; H J Järvinen; T A Miettinen
Journal:  Gut       Date:  1997-12       Impact factor: 23.059

Review 7.  Cardiovascular Safety of Biologics and JAK Inhibitors in Patients with Rheumatoid Arthritis.

Authors:  Eun Ha Kang; Katherine P Liao; Seoyoung C Kim
Journal:  Curr Rheumatol Rep       Date:  2018-05-30       Impact factor: 4.592

8.  Plasma cholesterol homeostasis, HDL remodeling and function during the acute phase reaction.

Authors:  Francesca Zimetti; Stefano De Vuono; Monica Gomaraschi; Maria Pia Adorni; Elda Favari; Nicoletta Ronda; Maria Anastasia Ricci; Fabrizio Veglia; Laura Calabresi; Graziana Lupattelli
Journal:  J Lipid Res       Date:  2017-08-22       Impact factor: 5.922

Review 9.  Update on adrenal insufficiency in patients with liver cirrhosis.

Authors:  Anca Trifan; Stefan Chiriac; Carol Stanciu
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

10.  HDL Mimetic Peptide Administration Improves Left Ventricular Filling and Cardiac output in Lipopolysaccharide-Treated Rats.

Authors:  Geeta Datta; Himanshu Gupta; Zhenghao Zhang; Palgunachari Mayakonda; G M Anantharamaiah; C Roger White
Journal:  J Clin Exp Cardiolog       Date:  2011-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.